Ching‐Chi Lee
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 30
- Epidemiology 43
- Sepsis Diagnosis and Treatment 35
- Urinary Tract Infections Management 4
- Co-authors
- Wen‐Chien Ko (96 shared papers)Nan–Yao Lee (47 shared papers)Chia‐Ming Chang (32 shared papers)Ming‐Yuan Hong (30 shared papers)Po‐Lin Chen (31 shared papers)Chung-Hsun Lee (24 shared papers)Chih‐Chia Hsieh (32 shared papers)Hsin–Chun Lee (20 shared papers)
- Journals
- Journal of Microbiology Immunology and Infection (24 papers)The American Journal of Emergency Medicine (14 papers)Diagnostic Microbiology and Infectious Disease (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)Antibiotics (6 papers)
- Partner nations
- TaiwanNew ZealandUnited States
In The Last Decade
Ching‐Chi Lee
115 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 99
- Molecular Medicine 630
- Applied Microbiology and Biotechnology 221
- Clinical Biochemistry 189
- Endocrinology 151
- Epidemiology 609
Countries citing papers authored by Ching‐Chi Lee
This map shows the geographic impact of Ching‐Chi Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Chi Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Chi Lee more than expected).
Fields of papers citing papers by Ching‐Chi Lee
This network shows the impact of papers produced by Ching‐Chi Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Chi Lee. The network helps show where Ching‐Chi Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching‐Chi Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 157 | |
| 2 | 2012 | 114 | |
| 3 | 2017 | 88 | |
| 4 | 2022 | 75 | |
| 5 | 2015 | 69 | |
| 6 | 2021 | 67 | |
| 7 | 2010 | 55 | |
| 8 | 2011 | 55 | |
| 9 | 2011 | 53 | |
| 10 | 2008 | 52 | |
| 11 | 2010 | 48 | |
| 12 | 2014 | 48 | |
| 13 | 2014 | 44 | |
| 14 | 2010 | 43 | |
| 15 | 2012 | 42 | |
| 16 | 2016 | 39 | |
| 17 | 2019 | 38 | |
| 18 | 2012 | 37 | |
| 19 | 2015 | 34 | |
| 20 | 2015 | 34 |
About Ching‐Chi Lee
Ching‐Chi Lee is a scholar working on Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology, Infectious Diseases and Endocrinology, having authored 122 papers that have together received 2.3k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (35 papers), Antibiotic Resistance in Bacteria (30 papers), Antibiotic Use and Resistance (15 papers), Clostridium difficile and Clostridium perfringens research (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Bacterial Identification and Susceptibility Testing (10 papers), Infections and bacterial resistance (9 papers) and Urinary Tract Infections Management (4 papers). The work is most often cited by research in Molecular Medicine (630 citations), Applied Microbiology and Biotechnology (221 citations), Clinical Biochemistry (189 citations), Endocrinology (151 citations) and Epidemiology (609 citations). Ching‐Chi Lee has collaborated with scholars based in Taiwan, New Zealand and United States. Frequent co-authors include Wen‐Chien Ko, Nan–Yao Lee, Chia‐Ming Chang, Ming‐Yuan Hong, Po‐Lin Chen, Chung-Hsun Lee, Chih‐Chia Hsieh, Hsin–Chun Lee, Ming-Chi Li and Yuan‐Pin Hung. Their work appears in journals such as Journal of Microbiology Immunology and Infection, The American Journal of Emergency Medicine, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy and Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.